WHO ICTRP trial
EUCTR2011-004232-66-FR · CHU de Clermont-Ferrand
EUCTR2011-004232-66-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-004232-66-FR |
|---|---|
| Primary sponsor | CHU de Clermont-Ferrand |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France |
| Conditions | Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03] |
| Interventions | Trade Name: NORADRENALINE (TARTRATE) AGUETTANT 2 mg/ml (SANS SULFITES) sol diluer p perf Product Name: norépinéphrine tartrate Pharmaceutical Form: Injection Other descriptive name: NORADRENALINE TARTRATE Concentration unit: mg/ml… |
| Registration date | Sep 20, 2011 |
| Target size | 300 |
| Secondary IDs | AOIFUTIER2011 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: